Publication: 2501

Publication: 2501

Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: The Cancer and Leukemia Group B (study 9730).

PubMed

DOI

Google Scholar

Citation:: J Clin Oncol vol 23 (1) 190-6

Year:: 2005
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: Respiratory
Sec. Committees:

Pharmas:
Grants:: CA03927, CA04457, CA11789, CA12046, CA21060, CA31946, CA32291, CA33601, CA41287, CA45564, CA52784, CA77651

Corr. Author:
Authors:: Rogerio C Lilenbaum James E Herndon Marcy A List Chris Desch Dorothy M Watson Antonius A Miller Stephen L Graziano Michael C Perry Wayne Saville Philippe Chahinian Jane C Weeks Jimmie C Holland Mark R Green

Networks:

Study: CALGB-9730
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords:: Adult, Aged, Aged, 80 and over, Antineoplastic Agents, Phytogenic, Antineoplastic Combined Chemotherapy Protocols, Carboplatin, Carcinoma, Non-Small-Cell Lung, Female, Humans, Lung Neoplasms, Male, Middle Aged, Paclitaxel, Survival Rate